Clinical Trial Update: Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD [Phase 1]

View source ↗

Summary

Phase 1 clinical trial registration for IxCell hUC-MSC-P, a human umbilical cord mesenchymal stem cell product, in connective tissue disease–associated intersti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease

Drugs mentioned

• IxCell hUC-MSC-P (human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Shanghai IxCell Biotechnology Co., LTD | Conditions: CTD-ILD | Phase 1 | Status: NOT_YET_RECRUITING